Dishman Carbogen Amcis Ltd vs Sudeep Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 12, 2026

Key Highlights

The Latest Trading Price of Dishman Carbogen Amcis Ltd is ₹ 185.25 as of 12 Jun 10:40 . The P/E Ratio of Dishman Carbogen Amcis Ltd changed from 161 on March 2022 to 1036 on March 2025 . This represents a CAGR of 59.28% over 4 yearsThe P/E Ratio of Sudeep Pharma Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Dishman Carbogen Amcis Ltd changed from ₹ 1708 crore on March 2021 to ₹ 3411 crore on March 2025 . This represents a CAGR of 14.83% over 5 yearsThe Market Cap of Sudeep Pharma Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Dishman Carbogen Amcis Ltd for the Mar '26 is ₹ 867.82 crore as compare to the Dec '25 revenue of ₹ 726.46 crore. This represent the growth of 19.46% The revenue of Sudeep Pharma Ltd for the Mar '26 is ₹ 188.76 crore as compare to the Dec '25 revenue of ₹ 179.17 crore. This represent the growth of 5.35% The ebitda of Dishman Carbogen Amcis Ltd for the Mar '26 is ₹ 178.22 crore as compare to the Dec '25 ebitda of ₹ 119.77 crore. This represent the growth of 48.8% The ebitda of Sudeep Pharma Ltd for the Mar '26 is ₹ 69.02 crore as compare to the Dec '25 ebitda of ₹ 66.81 crore. This represent the growth of 3.31% The net profit of Dishman Carbogen Amcis Ltd changed from ₹ -77.57 crore to ₹ 21.74 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Sudeep Pharma Ltd changed from ₹ 17.08 crore to ₹ 48.54 crore over 8 quarters. This represents a CAGR of 68.58% The Dividend Payout of Dishman Carbogen Amcis Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sudeep Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Limited was formerly incorporated as 'Carbogen Amcis (India) Limited' on July 17, 2007.
The Company name later on, was changed to 'Dishman Carbogen Amcis Limited' on 27 March 2017.
The Company is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants.
It works manufacturing and research facilities in India, Switzerland, France, The Netherland and China. During the financial year ended 31 March 2017, Dishman Pharmaceuticals and Chemicals Limited (DPCL) and Dishman Care Limited were merged with DPCL's subsidiary Carbogen Amcis (India) Limited, with the key objective of business consolidation and simplification of the Group structure.
The name of Carbogen Amcis (India) Ltd.

About Sudeep Pharma Ltd

Sudeep Pharma Limited was incorporated as Sudeep Pharma Private Limited' as a private limited company dated December 21, 1989, issued by the Registrar of Companies, Ahmedabad.
Thereafter, Company was converted into a public limited company and the name of the Company was changed to Sudeep Pharma Limited' pursuant to fresh certificate of incorporation dated April 5, 1995, issued by the Assistant Registrar of Companies, Gujarat at Dadra & Nagar Haveli.
Company was subsequently converted back to a private limited company vide a fresh certificate of incorporation dated October 1, 2014 issued by the Assistant Registrar of Companies, Gujarat at Ahmedabad, and the name of Company was accordingly changed from Sudeep Pharma Limited' to Sudeep Pharma Private Limited'.
Further, Company was converted into a public limited company and consequently, the name of Company was changed to Sudeep Pharma Limited'.

FAQs for the comparison of Dishman Carbogen Amcis Ltd and Sudeep Pharma Ltd

Which company has a larger market capitalization, Dishman Carbogen Amcis Ltd or Sudeep Pharma Ltd?

Market cap of Dishman Carbogen Amcis Ltd is 2,772 Cr while Market cap of Sudeep Pharma Ltd is 8,235 Cr

What are the key factors driving the stock performance of Dishman Carbogen Amcis Ltd and Sudeep Pharma Ltd?

The stock performance of Dishman Carbogen Amcis Ltd and Sudeep Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dishman Carbogen Amcis Ltd and Sudeep Pharma Ltd?

As of June 12, 2026, the Dishman Carbogen Amcis Ltd stock price is INR ₹176.85. On the other hand, Sudeep Pharma Ltd stock price is INR ₹729.1.

How do dividend payouts of Dishman Carbogen Amcis Ltd and Sudeep Pharma Ltd compare?

To compare the dividend payouts of Dishman Carbogen Amcis Ltd and Sudeep Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.